Biodegradable polymers as encapsulation materials for cosmetics and personal care markets

International Journal of Cosmetic Science

Volumn 35, Issue 2, 2013, Pages 113-124

  Ammala, Anne ^a  

^a CSIRO   (Australia)

Author keywords

biodegradable polymers; controlled release; cosmetics; encapsulation; polymeric carrier

Indexed keywords

ALGINIC ACID; ANTI ACNE AGENT; BIODEGRADABLE POLYMER; BIOLIN SEBO CARE; BIOLIN SEBO CARE IMPURE SKIN CREAM; CELLUTEX; CHITOSAN; COSMETIC; CYCLODEXTRIN; DENDRIMER; HYALURONIC ACID; KLORANE; KLORANE EXTRA GENTLE DRY SHAMPOO; LIPO CD E; LIPO CD OMC; LIPO CD SA; MIRAKELLE; NOVO FLEX; PENETRATION ENHANCING AGENT; POLYALKYLCYANOACRYLATE; POLYAMIDOAMINE; POLYCAPROLACTONE; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIDE; POLYMER; POLYSACCHARIDE; SELF ACTION SUPER TAN; SHAMPOO; STARCH; SUNSCREEN; UNCLASSIFIED DRUG;

BIOAVAILABILITY; CHEMICAL STRUCTURE; DRUG DELIVERY SYSTEM; ELECTROPORATION; IONTOPHORESIS; MICRONEEDLING; NANOENCAPSULATION; REVIEW; SKIN CARE; SKIN PENETRATION; SKIN STRUCTURE; SONOPHORESIS;

BIOCOMPATIBLE MATERIALS; BIOLOGICAL AVAILABILITY; COSMETICS; DRUG CARRIERS; HUMANS; POLYMERS; SKIN ABSORPTION;

EID: 84874948529     PISSN: 01425463     EISSN: 14682494     Source Type: Journal    
DOI: 10.1111/ics.12017     Document Type: Review

References (78)

1. Kumari, A., Yadav, S.K., and, Yadav, S.C., Biodegradable polymeric nanoparticles based drug delivery systems. Colloid Surf B-Biointerfaces. 75, 1-18 (2010).
2. Piskin, E., Biodegradable polymers as biomaterials. J. Biomater. Sci. Polymer. Edn. 6, 775-795 (1994).
3. Prausnitz, M.R., Mitragotri, S., and, Langer, R., Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov. 3, 115-124 (2004). (Pubitemid 38239773)
4. Winsor, T., and, Burch, G.E., Rate of invisible perspiration through living and dead stratum corneum. Arch. Int. Med. 74, 437 (1944).
5. Monash, H., Location of the superficial barrier to skin penetration. J. Invest. Derm. 29, 367 (1957).
6. Malkinson, F.D., Studies in the percutaneous absorption of C14 labeled steroid by use of the gas flow cell. J. Invest. Derm. 31, 19 (1958).
7. Kligman, A.M., The biology of the stratum corneum. In: The Epidermis. (, Montagna, W., Lobitz, W.B., eds.), pp. 387-433. Academic Press, New York (1964).
8. Blank, I.H., Transport across the stratum corneum. Toxicol. Appl. Pharmacol. 14, (Supplement 3) 23-29 (1969).
9. Blank, I.H., and, Scheuplein, R.J., Permeability of the skin. Physiol. Rev. 51, 702-747 (1971).
10. Elias, P.M., The epidermal permeability barrier: from the early days at harvard to emerging concepts. J. Investig. Dermatol. 122, xxxvi-xxxix (2004). (Pubitemid 38281039)
11. Association of the British Pharmaceutical Industry (ABPI). Skin Structure and Function. Available at: http://www.abpischools.org.uk/page/modules/skin/ skin2.cfm, accessed 27 March 2012.
12. Elias, P.M., Epidermal lipids, barrier function, and desquamation. J. Invest. Dermatol. 80 (1s), 44s-49s (1983). (Pubitemid 13063560)
13. Harding, C.R., The stratum corneum: structure and function in health and disease. Dermatol. Ther. 17, 6-15 (2004).
14. Förster, M., Bolzinger, M.-A., Fessi, H., and, Briançon, S., Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery. Eur. J. Derm. 19, 309-323 (2009).
15. Moghimi, H.R., Williams, A.C., and, Barry, B.W., Stratum corneum and barrier performance; a model lamellar structural approach. In: Percutaneous Absorption. (, Bronaugh, R.L., and, Maibach, H.I., eds.), pp. 515-553. Marcel Dekker, New York (1999).
16. Barbero, A.M., and, Frasch, H.F., Transcellular route of diffusion through stratum corneum: results from finite element models. J. Pharm. Sci. 95, 2186-2194 (2006). (Pubitemid 44568529)
17. Chen, L., Lian, G., and, Han, L., Use of "Bricks and Mortar" model to predict transdermal permeation: model development and initial validation. Ind. Eng. Chem. Res. 47, 6465-6472 (2008).
18. Chen, L., Lian, G., and, Han, L., Modeling transdermal permeation. Part I. Predicting skin permeability of both hydrophobic and hydrophilic solutes. AIChE J. 56, 1136-1146 (2010).
19. Mitragotri, S., Anissimov, Y.G., Bunge, A.L., et al,. Mathematical models of skin permeability: an overview. Int. J. Pharm. 418, 115-129 (2011).
20. Cross, S.E., and, Roberts, M.S., Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development? Curr. Drug Deliv. 1, 81-92 (2004).
21. Guy, R.H., Current status and future prospects of transdermal drug delivery. Pharm. Res. 13, 1765-1769 (1996). (Pubitemid 27034105)
22. Park, J.-H., Allen, M., and, Prausnitz, M., Polymer microneedles for controlled-release drug delivery. Pharm. Res. 23, 1008-1019 (2006). (Pubitemid 43781409)
23. Pawar, K.R., and, Babu, R.J., Polymeric and lipid-based materials for topical nanoparticle delivery systems. Crit. Rev. Ther. Drug Carr. Syst. 27, 419-459 (2010).
24. He, W., Guo, X., Xiao, L., and, Feng, M., Study on the mechanisms of chitosan and its derivatives used as transdermal penetration enhancers. Int. J. Pharm. 382, 234-243 (2009).
25. Cattaneo, M.V., Topical delivery systems based on polysaccharide microspheres. In: Delivery System Handbook for Personal Care and Cosmetic Products. (, Rosen, M.R., ed.), pp. 273-282. William Andrew, Inc., Norwich, NY (2005).
26. Cattaneo, M., Chitosan Microparticles for the Topical Delivery of Water Insoluble Active Agents. US patent 2004247632. IVREA, Inc., Qunicy, MA. (2004).
27. Wang, X., Xu, W., Mohapatra, S., Kong, X., Li, X., Lockey, R., and, Mohapatra, S., Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor. Genet. Vacc. Ther. 6, 7 (2008).
28. Mishra, N., Goyal, A.K., Khatri, K., et al,. Biodegradable polymer based particulate carrier(s) for the delivery of proteins and peptides. AntiInflam. Antiallergy Agents Med Chem 7, 240-251 (2008).
29. Ghosn, B., van de Ven, A.L., Tam, J., Gillenwater, A., Sokolov, K.V., Richards-Kortum, R., et al,. Efficient mucosal delivery of optical contrast agents using imidazole-modified chitosan. J. Biomed. Opt. 15, 015003 (2010).
30. Pedro, A.S., Cabral-Albuquerque, E., Ferreira, D., and, Sarmento, B., Chitosan: an option for development of essential oil delivery systems for oral cavity care? Carbohydr. Polym. 76, 501-508 (2009).
31. Basavaraj, K.H., Johnsy, G., Navya, M.A., Rashmi, R., and, Siddaramaiah,. Biopolymers as transdermal drug delivery systems in dermatology therapy. Crit. Rev. Ther. Drug. Carr. Syst. 27: 155-185 (2010).
32. Pavicic, T., Gauglitz, G.G., Lersch, P., Schwach-Abdellaoui, K., Malle, B., Korting, H.C., and, Farwick, M., Efficacy of cream-based novel formulations of Hyaluronic Acid of different molecular weights in anti-wrinkle treatment. J. Drugs Dermatol. 10, 990-1000 (2011).
33. Price, R.D., Berry, M.G., and, Navsaria, H.A., Hyaluronic acid: the scientific and clinical evidence. J. Plast. Reconstr. Aesthet. Surg. 60, 1110-1119 (2007). (Pubitemid 47342381)
34. Teh, B.M., Shen, Y., Friedland, P.L., Atlas, M.D., and, Marano, R.J., A review on the use of hyaluronic acid in tympanic membrane wound healing. Expert. Opin. Biol. Ther. 12, 23-36 (2012).
35. Abbruzzese, L., Rizzo, L., Fanelli, G., Tedeschi, A., Scatena, A., Goretti, C., Macchiarini, S., and, Piaggesi, A., Effectiveness and safety of a novel gel dressing in the management of neuropathic leg ulcers in diabetic patients: a prospective double-blind randomized trial. Int. J. Low Extrem. Wounds. 8, 134-140 (2009).
36. Kong, M., and, Park, H.J., Stability investigation of hyaluronic acid based nanoemulsion and its potential as transdermal carrier. Carbohydr. Polym. 83, 1303-1310 (2011).
37. Kong, M., Chen, X.G., Kweon, D.K., and, Park, H.J., Investigations on skin permeation of hyaluronic acid based nanoemulsion as transdermal carrier. Carbohydr. Polym. 86, 837-843 (2011).
38. Brown, M.B., and, Jones, S.A., Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. J. Eur. Acad. Derm. Venereol. 19, 308-318 (2005). (Pubitemid 40691707)
39. Matsuda, H., and, Arima, H., Cyclodextrins in transdermal and rectal delivery. Adv. Drug Deliv. Rev. 36, 81-99 (1999). (Pubitemid 29074478)
40. Gonnet, M., Lethuaut, L., and, Boury, F., New trends in encapsulation of liposoluble vitamins. J. Control Release. 146, 276-290 (2010).
41. Scalia, S., Villani, S., Scatturin, A., Vandelli, M.A., and, Forni, F., Complexation of the sunscreen agent, butyl-methoxydibenzoylmethane, with hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 175, 205-213 (1998). (Pubitemid 28517976)
42. Tarimci, N., Cyclodextrins in the cosmetic field. In: Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine: Current and Future Industrial Applications. (, Bilensoy, E., ed.), pp. 131-144. John Wiley & Sons, Inc., Hoboken, NJ (2011).
43. Kear, C.L., Yang, J., Godwin, D.A., and, Felton, L.A., Investigation into the mechanism by which cyclodextrins influence transdermal drug delivery. Drug Dev. Ind. Pharm. 34, 692-697 (2008). (Pubitemid 351962339)
44. Lee, K.Y., and, Mooney, D.J., Alginate: properties and biomedical applications. Prog. Polym. Sci. 37, 106-126 (2012).
45. Solomon, M.C., and, Oraceska, B., Cross-linked Alginate Transdermal Medicine Delivery Devices. US patent 5484604. Chatfield Pharmaceuticals Ltd., Kramer Mews, England, (1996).
46. Elmotasem, H., Chitosan-alginate blend films for the transdermal delivery of meloxicam. J. Pharm. Sci. 3, 12-29 (2008).
47. Handjani, R.M., Kauffmann, M., and, Huguenin, F., Process for the Preparation of Alginate Capsules, Apparatus for producing said Capsules and Cosmetic Compositions Containing said Capsules. US patent 5204111. L'Oreal, Paris, France, (1993).
48. Viyoch, J., Patcharaworakulchai, P., Songmek, R., Pimsan, V., and, Wittaya-Areekul, S., Formulation and development of a patch containing tamarind fruit extract by using the blended chitosan-starch as a rate-controlling matrix. Int. J. Cosmet. Sci. 25, 113-125 (2003). (Pubitemid 37041230)
49. Freers, S.O., Starch-based delivery systems. In: Delivery System Handbook for Personal Care and Cosmetic Products: Technology, Applications and Formulations. (, Rosen, M.R., ed.), pp. 741-760. William Andrew Inc., Norwich, NY (2005).
50. Wille, J.J., Methods for Preparation of a Thixotropic Microemulsion for Skin Care Formulations. US patent 2010098734. Individual, Chesterfield, NJ (2010).
51. Wille, J.J., Thixogel: a starch matrix encapsulation technology for topical drug and cosmetic delivery. In: Skin Delivery Systems: Transdermals, Dermatologicals and Cosmetic Actives. (, Wille, J.J., ed.), pp. 223-245. Blackwell Publishing, Oxford, UK (2006).
52. Mourtzinos, I., Papadakis, S.E., Igoumenidis, P., and, Karathanos, V.T., Encapsulation of Melissa Officinalis leaf's active compounds in β-cyclodextrin and modified starch. Procedia Food Science. 1, 1679-1685 (2011).
53. Compton, D.L., Kenar, J.A., Laszlo, J.A., and, Felker, F.C., Starch-encapsulated, soy-based, ultraviolet-absorbing composites with feruloylated monoacyl- and diacylglycerol lipids. Ind. Crops Prod. 25, 17-23 (2007). (Pubitemid 44959869)
54. Sinha, V.R., Bansal, K., Kaushik, R., Kumria, R., and, Trehan, A., Poly-&epsi-caprolactone microspheres and nanospheres: an overview. Int. J. Pharm. 278, 1-23 (2004).
55. Cha, Y., and, Pitt, C.G., The biodegradability of polyester blends. Biomaterials 11, 108-112 (1990). (Pubitemid 20119319)
56. Vaida, C., Mela, P., Kunna, K., Sternberg, K., Keul, H., and, Möller, M., Microparticles for drug delivery based on functional polycaprolactones with enhanced degradability: loading of hydrophilic and hydrophobic active compounds. Macromol. Biosci. 10, 925-933 (2010).
57. Sinha, V.R., and, Trehan, A., Biodegradable microspheres for protein delivery. J. Control Release. 90, 261-280 (2003). (Pubitemid 36859959)
58. Ye, M., Kim, S., and, Park, K., Issues in long-term protein delivery using biodegradable microparticles. J Control Release. 146, 241-260 (2010).
59. Gu, H., and, Roy, K., Topical permeation enhancers efficiently deliver polymer micro and nanoparticles to epidermal Langerhans' cells. J. Drug Deliv. Sci. Tech. 14, 265-273 (2004). (Pubitemid 39159105)
60. Kim, H., Kim, M., Quan, Y., et al,. Novel anti-wrinkle effect of cosmeceutical product with new retinyl retinoate microsphere using biodegradable polymer. Skin Res. Tech. 18, 70-76 (2012).
61. Haddadi, A., Aboofazeli, R., Erfan, M., and, Farboud, E.S., Topical delivery of urea encapsulated in biodegradable PLGA microparticles: O/W and W/O creams. J. Microencapsul. 25, 379-386 (2008).
62. Stevanovic̈, M., Savic̈, J., Jordovic̈, B., and, Uskokovic̈, D., Fabrication, in vitro degradation and the release behaviours of poly(dl-lactide-co-glycolide) nanospheres containing ascorbic acid. Colloids Surf., B 59, 215-223 (2007). (Pubitemid 47214610)
63. Alvarez-Román, R., Naik, A., Kalia, Y., Guy, R.H., and, Fessi, H., Skin penetration and distribution of polymeric nanoparticles. J. Control Release. 99, 53-62 (2004). (Pubitemid 39165733)
64. Dermabond topical skin adhesive. Int. J. Trauma Nurs. 5: 29-31 (1999).
65. Handjani, R.-M., and, Ribier, A., Composition for the Cosmetic and/or Pharmaceutical Treatment of the Upper Layers of the Epidermis by Topical Application to the Skin, and Corresponding Preparation Process. US patent 20010010824. L'Oreal, Paris, France (2001).
66. Eichman, J.D., Bielinska, A.U., Kukowska-Latallo, J.F., Donovan, B.W., and, Baker, J.R., Bioapplications of PAMAM Dendrimers. In: Dendrimers and Other Dendritic Polymers. (, Frechet, J.M.J., and, Tomalia, D.A., eds.), pp. 441-461. John Wiley & Sons, Ltd, New York (2002).
67. Parveen, S., Misra, R., and, Sahoo, S.K., Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomed. Nanotechnol. Biol. Med. 8, 147-166 (2012).
68. Mourey, T.H., Turner, S.R., Rubinstein, M., Frechet, J.M.J., Hawker, C.J., and, Wooley, K.L., Unique behaviour of dendritic macromolecules-intrinsic viscosity of polyether dendrimers. Macromolecules 25, 2401-2406 (1992).
69. Tournilhac, F., and, Simon, P., Cosmetic or Dermatological Topical Compositions Comprising Dendritic Polyesters. US patent US6287552. L'Oreal, Paris, France (2001).
70. Forestier, S., Rollat-Corvol, I., and, Rollat, C.I., Deodorant Composition and Use Thereof patent US6001342. L'Oreal, Paris, France (1999).
71. Allard, D., and, Forestier, S., Composition Comprises Active Self Bronzing Agent and Dendrimer Type Polymer-used for Artificial Tanning of Skin, gives more Rapid Development of Skin Colour and Brown Shade which closely resembles Natural Sun Tanning Patent US6399048-B1. L'Oreal, Paris, France (2002).
72. Snyder, F., Wolf, B.A., and, Snyden, F., Cosmetic Compositions having Keratolytic and Anti-Acne Activity. US patent 5449519. Revlon Consumer products Corp. New York, NY, (1995).
73. Filipowicz, A., and, Wołowiec, S., Solubility and in vitro transdermal diffusion of riboflavin assisted by PAMAM dendrimers. Int. J. Pharm. 408, 152-156 (2011).
74. Cheng, Y., Qu, H., Ma, M., Xu, Z., Xu, P., Fang, Y., and, Xu, T., Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study. Eur. J. Med. Chem. 42, 1032-1038 (2007). (Pubitemid 46907335)
75. Starpharma Dendrimer Platform Technology. Available at: http://www.starpharma.com/, accessed 9 August 2012.
76. Sun, M.J., Fan, A.P., Wang, Z., and, Zhao, Y.J., Dendrimer-mediated drug delivery to the skin. Soft Matter 8, 4301-4305 (2012).
77. Bilati, U., Allemann, E., and, Doelker, E., Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur. J. Pharm. Biopharm. 59, 375-388 (2005). (Pubitemid 40342512)
78. Perez, C., Castellanos, I.J., Costantino, H.R., Al-Azzam, W., and, Griebenow, K., Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers. J. Pharm. Pharmacol. 54, 301-313 (2002). (Pubitemid 34232331)